BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fatemi I, Shamsizadeh A, Ayoobi F, Taghipour Z, Sanati MH, Roohbakhsh A, Motevalian M. Role of orexin-A in experimental autoimmune encephalomyelitis. J Neuroimmunol 2016;291:101-9. [PMID: 26857503 DOI: 10.1016/j.jneuroim.2016.01.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Hakimizadeh E, Kaeidi A, Taghipour Z, Mehrzadi S, Allahtavakoli M, Shamsizadeh A, Bazmandegan G, Hassanshahi J, Aflatoonian MR, Fatemi I. Ceftriaxone improves senile neurocognition damages induced by D-galactose in mice. Iran J Basic Med Sci 2020;23:368-75. [PMID: 32440324 DOI: 10.22038/IJBMS.2019.40344.9556] [Reference Citation Analysis]
2 Ayoobi F, Shamsizadeh A, Fatemi I, Vakilian A, Allahtavakoli M, Hassanshahi G, Moghadam-Ahmadi A. Bio-effectiveness of the main flavonoids of Achillea millefolium in the pathophysiology of neurodegenerative disorders- a review. Iran J Basic Med Sci 2017;20:604-12. [PMID: 28868116 DOI: 10.22038/IJBMS.2017.8827] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
3 Fatemi I, Khaluoi A, Kaeidi A, Shamsizadeh A, Heydari S, Allahtavakoli MA. Protective effect of metformin on D-galactose-induced aging model in mice. Iran J Basic Med Sci 2018;21:19-25. [PMID: 29372032 DOI: 10.22038/IJBMS.2017.24331.6071] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
4 Delrobaei F, Fatemi I, Shamsizadeh A, Allahtavakoli M. Ascorbic acid attenuates cognitive impairment and brain oxidative stress in ovariectomized mice. Pharmacological Reports 2019;71:133-8. [DOI: 10.1016/j.pharep.2018.10.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
5 Burfeind KG, Yadav V, Marks DL. Hypothalamic Dysfunction and Multiple Sclerosis: Implications for Fatigue and Weight Dysregulation. Curr Neurol Neurosci Rep 2016;16:98. [PMID: 27662896 DOI: 10.1007/s11910-016-0700-3] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 3.4] [Reference Citation Analysis]
6 Wang D, Ren H, Li C, Liu F, Wang G, Shi F, Sun Y. Orexin A prevents degradation of the articular matrixes in human primary chondrocyte culture. Molecular Immunology 2018;101:102-7. [DOI: 10.1016/j.molimm.2018.05.012] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Couvineau A, Voisin T, Nicole P, Gratio V, Abad C, Tan YV. Orexins as Novel Therapeutic Targets in Inflammatory and Neurodegenerative Diseases. Front Endocrinol (Lausanne) 2019;10:709. [PMID: 31695678 DOI: 10.3389/fendo.2019.00709] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
8 Wang X, Wang H, Li H. Inhibition of iNOS ameliorates traumatic stress-induced deficits in synaptic plasticity and memory. Psychiatry Research 2018;268:413-8. [DOI: 10.1016/j.psychres.2018.08.028] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
9 Anderson G, Rodriguez M, Reiter RJ. Multiple Sclerosis: Melatonin, Orexin, and Ceramide Interact with Platelet Activation Coagulation Factors and Gut-Microbiome-Derived Butyrate in the Circadian Dysregulation of Mitochondria in Glia and Immune Cells. Int J Mol Sci 2019;20:E5500. [PMID: 31694154 DOI: 10.3390/ijms20215500] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
10 Pallais JP, Kotz CM, Stanojlovic M. Orexin/hypocretinin in multiple sclerosis and experimental autoimmune encephalomyelitis. Neural Regen Res 2020;15:1039-40. [PMID: 31823881 DOI: 10.4103/1673-5374.270310] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Hadadianpour Z, Fatehi F, Ayoobi F, Kaeidi A, Shamsizadeh A, Fatemi I. The effect of orexin-A on motor and cognitive functions in a rat model of Parkinson’s disease. Neurological Research 2017;39:845-51. [DOI: 10.1080/01616412.2017.1352185] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
12 Nasiri Ansari N, Spentza F, Dimitriadis GK, Daskalopoulou A, Karapanagioti A, Siasos G, Lianidou E, Papavassiliou AG, Kassi E, Randeva HS. Orexin-A Exerts Equivocal Role in Atherosclerosis Process Depending on the Duration of Exposure: In Vitro Study. Nutrients 2019;12:E53. [PMID: 31878149 DOI: 10.3390/nu12010053] [Reference Citation Analysis]
13 Niknia S, Kaeidi A, Hajizadeh MR, Mirzaei MR, Khoshdel A, Hajializadeh Z, Fahmidehkar MA, Mahmoodi M. Neuroprotective and antihyperalgesic effects of orexin-A in rats with painful diabetic neuropathy. Neuropeptides 2019;73:34-40. [DOI: 10.1016/j.npep.2018.11.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
14 Goudarzi M, Mombeini MA, Fatemi I, Aminzadeh A, Kalantari H, Nesari A, Najafzadehvarzi H, Mehrzadi S. Neuroprotective effects of Ellagic acid against acrylamide-induced neurotoxicity in rats. Neurological Research 2019;41:419-28. [DOI: 10.1080/01616412.2019.1576319] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 8.0] [Reference Citation Analysis]
15 Wang Q, Cao F, Wu Y. Orexinergic System in Neurodegenerative Diseases. Front Aging Neurosci 2021;13:713201. [PMID: 34483883 DOI: 10.3389/fnagi.2021.713201] [Reference Citation Analysis]
16 Becquet L, Abad C, Leclercq M, Miel C, Jean L, Riou G, Couvineau A, Boyer O, Tan YV. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation. J Neuroinflammation 2019;16:64. [PMID: 30894198 DOI: 10.1186/s12974-019-1447-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]